Navigation Links
Two Drugs Found Equal in Treatment of Septic Shock
Date:2/27/2008

But vasopressin might be slightly better than norepinephrine in less severe cases

WEDNESDAY, Feb. 27 (HealthDay News) -- The artery-tightening medication vasopressin holds no overall advantage over an older drug, norepinephrine, in the treatment of severe septic shock, a new study finds.

But vasopressin did appear to be better for less severe cases in the study, said Dr. James. A Russell, a professor of medicine at the University of British Columbia and lead author of a report in the Feb. 28 issue of the New England Journal of Medicine.

Septic shock occurs when an infection, usually bacterial, overwhelms the body's natural defenses, causing drastic drops in blood pressure and blood flow. Quick treatment to raise blood pressure can reduce the death rate, which is high. In this study, more than 35 percent of those treated with either drug died in the first four weeks.

"Vasopressin has been widely used for the treatment of septic shock because of studies showing an improvement in blood pressure and function," Russell said. "There has never been a large study examining the effect on mortality. Our study showed that basically, vasopressin and norepinephrine are safe and equally effective overall."

The study included 778 people treated for septic shock in a number of hospitals in Canada, Australia and the United States. In the first 28 days, 35.4 percent of those given vasopressin and 39.3 percent of those treated with norepinephrine died -- a difference that was not statistically significant.

But there was a statistically significant difference among those with less severe septic shock, defined by the dose of norepinephrine needed to raise blood pressure the desired amount, Russell said. In that group -- about half the people in the study -- 26.5 percent of those given vasopressin died, compared to 35.7 percent of those given norepinephrine. The death rate for more severe cases was 44 percent with vasopressin treatment, 42.5 percent with norepinephrine treatment.

"In our hospital, patients with less severe septic shock are being treated with vasopressin," Russell said.

But perhaps the most important factor in treatment is time, said Dr. Joseph E. Parrillo, a professor of medicine at Robert Wood Johnson Medical School in Camden, N.J.

"Two previous papers suggest that the support you give to the patient, fluids and a vasopressor, are only effective if instituted within the first few hours after the onset of septic shock," Parrillo said. "One paper also suggested that giving an antibiotic early made a difference, with a 20 percent death rate if an antibiotic was given in the first hour, and 60 percent if given by hour six."

The choice of antibiotic to treat the infection underlying the condition is also important, he said. "It makes a difference if you use antibiotics to which the infectious organism is sensitive," Parrillo said. A broad-spectrum antibiotic is adequate in most cases, he added.

Recent guidelines issued in a joint effort by 11 medical organizations, led by the Society of Critical Care Medicine, stress the need for early antibiotic treatment, Parrillo said. The guidelines do not stress the use of one artery-tightening medication over another, but, "the feeling is that there is no reason to use vasopressin," he said.

More information

Causes and treatment of septic shock are described by the U.S. National Library of Medicine.



SOURCES: James A. Russell, professor, medicine, University of British Columbia, Vancouver, British Columbia, Canada; Joseph E. Parrillo, M.D., professor, medicine, Robert Wood Johnson Medical School, Camden, N.J.; Feb. 28, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
2. Drugs used for cancer-associated anemia linked with increased risk of blood clots, death
3. Anemia Drugs for Cancer Patients Increase Death Risk
4. China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd.
5. Many Patients Fail to Take Drugs After Heart Attack
6. Cure Diabetes with Weight Loss, Not Drugs, Expert Says
7. Drugs, Doctors and Death: Heath Ledger Becomes Another Victim
8. The Northern Illinois University Murders Due to Chemical Imbalances or Chemical Balancers - Drugs? - Fred A. Baughman Jr., MD, Neurologist/Child Neurologist
9. New understanding of how big molecules bind will lead to better drugs, synthetic organic materials
10. Cholesterol-Lowering Drugs May Ease Irregular Heartbeat
11. Free Drugs After Heart Attack Would Save Money, Lengthen Lives
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Drugs Found Equal in Treatment of Septic Shock
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: